Healthcare -
Biotechnology - NASDAQ - US
$ 5.49
-4.85 %
$ 801 M
Market Cap
-1.56
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
89bio, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 385 M |
| Operating Income | -385 M |
| Other Expenses | -17.6 M |
| Net Income | -367 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0 | 0.3 | 0.2 | 79 K | 60 K | 17 K | 6 K |
| Gross Profit | 0 | (0.3) | (0.2) | 79 K | 60 K | 17 K | 6 K |
| OPERATING INCOME | |||||||
| Operating Expenses | 384.7 | 151.2 | 102.2 | 89.7 | 49.4 | 26.6 | 15.2 |
| Selling, General and Administrative Expenses | 39.6 | 29.0 | 21.5 | 19.4 | 13.2 | 5.3 | 1.5 |
| Research and Development Expenses | 345.0 | 122.2 | 80.8 | 70.3 | 36.2 | 21.3 | 13.7 |
| Operating Income | (384.7) | (151.2) | 102.2 | (89.7) | (49.4) | (26.6) | (15.2) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | (5.3) | 3.6 | 1.9 | 0.7 | 0 | 0 | 0 |
| Total Other Income | 18.3 | 12.9 | 0.2 | (0.5) | (0.2) | (30.6) | (1.0) |
| Pre-Tax Income | (366.4) | (138.3) | (102.0) | (90.3) | (49.6) | (57.2) | (16.1) |
| NET INCOME | |||||||
| Tax Provision | (0.7) | 3.9 | 19 K | (0.1) | 59 K | 0.2 | 28 K |
| Net Income | (367.1) | (142.2) | (102.0) | (90.1) | (49.5) | (57.4) | (16.2) |
| EPS | 3.51 | 2 | 2.93 | 4.48 | 3.08 | 5.4 | 3.53 |